Review compares recovery methods for muscle soreness after exercise
The analysis found different patterns for soreness, creatine kinase, and interleukin-6, but confidence varied by outcome and comparison.
High evidenceReviewSome caution advised
Medical disclaimer: This article summarizes research findings and is for informational purposes only. It is not medical advice.
Editorial illustration — not from the study.
This systematic review and network meta-analysis compared multiple recovery approaches during the early period after exercise. The researchers examined delayed-onset muscle soreness and laboratory markers including creatine kinase and interleukin-6 at different time points.
The results suggested that whole-body cryotherapy and phototherapy-related interventions were linked with larger reductions in soreness at 24 and 48 hours than the combined control or placebo condition. Low-level laser therapy and phototherapy-related interventions were associated with lower creatine kinase levels. These findings compare estimated average effects across studies; they do not establish that one method is appropriate for every person or type of exercise.
What the review covered
The researchers systematically searched PubMed, Embase, the Cochrane Library, and Web of Science for randomized controlled trials, including parallel-group and crossover studies. They included 35 studies and used a Bayesian random-effects network meta-analysis to compare several post-exercise recovery interventions. The abstract does not specify the total number of participants, their ages or health characteristics, or whether all included trials involved humans, although randomized post-exercise intervention trials generally study people. Risk of bias was assessed with the revised Cochrane RoB 2 tool, and confidence in the network estimates was assessed with CINeMA.
What the review concluded
For delayed-onset muscle soreness, whole-body cryotherapy had estimated mean differences versus the combined control or placebo condition of −38.92 at 24 hours and −40.03 at 48 hours. Phototherapy-related interventions had estimated mean differences of −18.20 at 24 hours and −19.46 at 48 hours. The abstract does not state the soreness scale or units, so the practical size of these differences cannot be judged from the reported numbers alone.
For creatine kinase, low-level laser therapy and phototherapy-related interventions were associated with lower estimated levels at both 24 and 48 hours. The largest reported estimate was for low-level laser therapy at 48 hours: −499.96, with a 95% credible interval from −831.59 to −203.59. The units and clinical meaning of this difference are not provided. Cold-water immersion had favorable estimates for interleukin-6 at 24 and 48 hours, but the researchers described this evidence as exploratory because the evidence base was limited and the comparison network was sparse.
Who this is relevant to
These findings may be relevant to populations and exercise situations similar to those represented in the included trials, but the abstract does not provide enough information to identify those populations. They may not apply to people with medical conditions, different training levels, different types or intensities of exercise, or recovery periods beyond the early time points studied. Because this was a review of research studies rather than a single intervention trial, the results do not establish that any specific method will produce the same effects for every person.
Why it matters
The review addresses a practical research question: whether different post-exercise methods show different patterns for soreness and biological markers during early recovery. It also illustrates that an intervention may have different findings depending on the outcome measured and the time point examined. Creatine kinase and interleukin-6 are laboratory markers and do not by themselves establish how a person feels or how quickly they has recovered. The findings should therefore be viewed as comparative research evidence, not as a ranking of recovery methods or a clinical recommendation.
Limitations & evidence assessment
The review included only 35 studies, and the abstract does not report the total sample size, participant characteristics, intervention details, or the quality rating for each outcome. Network meta-analysis estimates depend on the underlying trials and on the comparability of their participants, protocols, controls, and outcome measurements. The interleukin-6 network was sparse, making those findings particularly uncertain. Follow-up focused on early recovery, mainly 24 and 48 hours, so longer-term outcomes were not addressed. The abstract also notes that risk of bias and evidence confidence were assessed, but it does not provide their detailed results; therefore, the certainty of individual comparisons remains unclear.
Why this evidence level: Meta-analysis pooling multiple studies sits at the top of common evidence hierarchies.
Evidence levels are editorial estimates derived from study metadata — they are not clinical appraisals.
// Source
Frontiers in Bioengineering and Biotechnology · 2026 · DOI: 10.3389/fbioe.2026.1956053
Researchers combined genetic data from more than 1 million human participants to study factors associated with endometriosis. They identified 58 genomic regions, including 27 not previously reported, and used additional molecular analyses to implicate 314 genes. These findings point to possible biological pathways for further research, but they do not establish causes or demonstrate that any treatment will work.
Researchers systematically reviewed laboratory studies of how temperature affects the time it takes arboviruses to become transmissible inside mosquitoes. Across 53 studies covering 17 viruses, higher temperatures were generally linked with greater transmission efficiency and a shorter time to infectiousness for Zika and West Nile viruses, while results for several other viruses were unclear.
This systematic review and meta-analysis examined whether ultra-low-dose computed tomography (CT) can detect pulmonary, or lung, nodules while using less radiation than standard-dose CT. Across 42 studies involving 15,792 patients, pooled sensitivity for nodule detection was 91.9%, but results varied greatly between studies. The review also found that ultra-low-dose CT used an average effective dose of 0.22 millisieverts (mSv), while detection was less reliable for some small or hazy nodules and in patients with a high body mass index.